TEVA logo

TEVA Long term liabilities

Annual long term liabilities:

$20.81B-$2.30B(-9.94%)
December 31, 2024

Summary

  • As of today (May 31, 2025), TEVA annual total long term liabilities is $20.81 billion, with the most recent change of -$2.30 billion (-9.94%) on December 31, 2024.
  • During the last 3 years, TEVA annual long term liabilities has fallen by -$4.58 billion (-18.05%).
  • TEVA annual long term liabilities is now -47.42% below its all-time high of $39.58 billion, reached on December 31, 2016.

Performance

TEVA Long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAbalance sheet metrics

quarterly long term liabilities:

$20.99B+$179.00M(+0.86%)
March 31, 2025

Summary

  • As of today (May 31, 2025), TEVA quarterly total long term liabilities is $20.99 billion, with the most recent change of +$179.00 million (+0.86%) on March 31, 2025.
  • Over the past year, TEVA quarterly long term liabilities has dropped by -$449.00 million (-2.09%).
  • TEVA quarterly long term liabilities is now -50.54% below its all-time high of $42.43 billion, reached on September 30, 2016.

Performance

TEVA quarterly long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAbalance sheet metrics

Long term liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

TEVA Long term liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-9.9%-2.1%
3 y3 years-18.1%-16.7%
5 y5 years-27.6%-26.1%

TEVA Long term liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-18.1%at low-16.7%+0.9%
5 y5-year-27.6%at low-26.1%+0.9%
alltimeall time-47.4%>+9999.0%-50.5%>+9999.0%

TEVA Long term liabilities History

DateAnnualQuarterly
Mar 2025
-
$20.99B(+0.9%)
Dec 2024
$20.81B(-9.9%)
$20.81B(-3.6%)
Sep 2024
-
$21.58B(-0.7%)
Jun 2024
-
$21.74B(+1.4%)
Mar 2024
-
$21.44B(-7.2%)
Dec 2023
$23.11B(-3.5%)
$23.11B(-0.3%)
Sep 2023
-
$23.18B(-1.5%)
Jun 2023
-
$23.54B(-3.6%)
Mar 2023
-
$24.43B(+2.0%)
Dec 2022
$23.94B(-5.7%)
$23.94B(+3.2%)
Sep 2022
-
$23.20B(-7.6%)
Jun 2022
-
$25.11B(-0.3%)
Mar 2022
-
$25.19B(-0.8%)
Dec 2021
$25.39B(-3.9%)
$25.39B(+3.3%)
Sep 2021
-
$24.57B(-2.5%)
Jun 2021
-
$25.19B(-2.9%)
Mar 2021
-
$25.94B(-1.8%)
Dec 2020
$26.41B(-8.1%)
$26.41B(-2.3%)
Sep 2020
-
$27.04B(-4.8%)
Jun 2020
-
$28.42B(-0.0%)
Mar 2020
-
$28.42B(-1.1%)
Dec 2019
$28.73B(-6.0%)
$28.73B(+1.8%)
Sep 2019
-
$28.21B(-5.1%)
Jun 2019
-
$29.72B(-0.9%)
Mar 2019
-
$30.00B(-1.8%)
Dec 2018
$30.57B(-10.0%)
$30.57B(-1.7%)
Sep 2018
-
$31.10B(-7.0%)
Jun 2018
-
$33.45B(-2.6%)
Mar 2018
-
$34.32B(+1.1%)
Dec 2017
$33.95B(-14.2%)
$33.95B(-12.6%)
Sep 2017
-
$38.84B(-5.9%)
Jun 2017
-
$41.29B(+4.2%)
Mar 2017
-
$39.63B(+0.1%)
Dec 2016
$39.58B(+250.2%)
$39.58B(-6.7%)
Sep 2016
-
$42.43B(+269.4%)
Jun 2016
-
$11.49B(-1.2%)
Mar 2016
-
$11.63B(+2.9%)
Dec 2015
$11.30B(+4.9%)
$11.30B(-11.3%)
Sep 2015
-
$12.75B(-0.5%)
Jun 2015
-
$12.81B(+8.5%)
Mar 2015
-
$11.81B(+9.6%)
Dec 2014
$10.78B(-16.5%)
$10.78B(-4.4%)
Sep 2014
-
$11.27B(-0.2%)
Jun 2014
-
$11.29B(-9.4%)
Mar 2014
-
$12.46B(-3.5%)
Dec 2013
$12.91B(-13.1%)
$12.91B(-3.0%)
Sep 2013
-
$13.30B(+1.9%)
Jun 2013
-
$13.06B(+1.2%)
Mar 2013
-
$12.90B(-13.2%)
Dec 2012
$14.85B(+5.2%)
$14.85B(-6.5%)
Sep 2012
-
$15.88B(-0.6%)
Jun 2012
-
$15.98B(+17.2%)
Mar 2012
-
$13.64B(-3.4%)
Dec 2011
$14.12B(+118.8%)
$14.12B(+105.9%)
Sep 2011
-
$6.86B(+7.8%)
Jun 2011
-
$6.36B(-12.1%)
Mar 2011
-
$7.24B(+12.1%)
Dec 2010
$6.46B
$6.46B(-19.4%)
Sep 2010
-
$8.01B(+4.8%)
Jun 2010
-
$7.64B(+26.8%)
DateAnnualQuarterly
Mar 2010
-
$6.03B(-6.6%)
Dec 2009
$6.45B(-20.0%)
$6.45B(-4.6%)
Sep 2009
-
$6.76B(-5.6%)
Jun 2009
-
$7.16B(-5.0%)
Mar 2009
-
$7.54B(-6.5%)
Dec 2008
$8.06B(+88.3%)
$8.06B(+57.9%)
Sep 2008
-
$5.11B(+14.9%)
Jun 2008
-
$4.45B(0.0%)
Mar 2008
-
$4.45B(+3.9%)
Dec 2007
$4.28B(-18.0%)
$4.28B(-0.9%)
Sep 2007
-
$4.32B(-12.1%)
Jun 2007
-
$4.91B(-1.0%)
Mar 2007
-
$4.96B(-5.0%)
Dec 2006
$5.22B(+151.5%)
$5.22B(-4.1%)
Sep 2006
-
$5.45B(+0.1%)
Jun 2006
-
$5.44B(-0.0%)
Mar 2006
-
$5.44B(+162.0%)
Dec 2005
$2.08B(+2.4%)
$2.08B(+8.0%)
Sep 2005
-
$1.92B(-5.1%)
Jun 2005
-
$2.03B(+0.3%)
Mar 2005
-
$2.02B(-0.4%)
Dec 2004
$2.03B(+119.3%)
$2.03B(+0.1%)
Sep 2004
-
$2.02B(-6.7%)
Jun 2004
-
$2.17B(-1.6%)
Mar 2004
-
$2.21B(+138.6%)
Dec 2003
$924.90M(-27.1%)
$924.90M(+0.8%)
Sep 2003
-
$917.50M(-29.0%)
Jun 2003
-
$1.29B(+2.0%)
Mar 2003
-
$1.27B(-0.2%)
Dec 2002
$1.27B(-5.3%)
$1.27B(-7.2%)
Sep 2002
-
$1.37B(-0.8%)
Jun 2002
-
$1.38B(+2.1%)
Mar 2002
-
$1.35B(+0.8%)
Dec 2001
$1.34B(+45.7%)
$1.34B(-0.1%)
Sep 2001
-
$1.34B(+50.8%)
Jun 2001
-
$889.41M(-2.7%)
Mar 2001
-
$913.68M(-0.6%)
Dec 2000
$918.88M(+98.3%)
$918.88M(+76.0%)
Sep 2000
-
$522.00M(+27.8%)
Jun 2000
-
$408.40M(-4.7%)
Mar 2000
-
$428.68M(-7.5%)
Dec 1999
$463.46M(+94.1%)
$463.46M(+32.5%)
Sep 1999
-
$349.90M(+41.3%)
Jun 1999
-
$247.70M(+4.8%)
Mar 1999
-
$236.40M(-1.0%)
Dec 1998
$238.80M(+61.4%)
$238.80M(+9.5%)
Sep 1998
-
$218.00M(+1.1%)
Jun 1998
-
$215.70M(+65.8%)
Mar 1998
-
$130.10M(-12.1%)
Dec 1997
$148.00M(-19.8%)
$148.00M(-19.8%)
Dec 1996
$184.50M(+62.6%)
$184.50M(+62.6%)
Dec 1995
$113.50M(+21.0%)
$113.50M(+21.0%)
Dec 1994
$93.80M(+11.1%)
$93.80M(+11.1%)
Dec 1993
$84.40M(+62.0%)
$84.40M(+62.0%)
Dec 1992
$52.10M(-26.3%)
$52.10M(-26.3%)
Dec 1991
$70.70M(-22.8%)
$70.70M(-22.8%)
Dec 1990
$91.60M(+6.4%)
$91.60M(+6.4%)
Dec 1989
$86.10M(+47.4%)
$86.10M(+47.4%)
Dec 1988
$58.40M(+50.1%)
$58.40M(+50.1%)
Mar 1987
$38.90M(-14.7%)
$38.90M(-14.7%)
Mar 1986
$45.60M
$45.60M

FAQ

  • What is Teva Pharmaceutical Industries Limited annual total long term liabilities?
  • What is the all time high annual long term liabilities for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual long term liabilities year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly long term liabilities year-on-year change?

What is Teva Pharmaceutical Industries Limited annual total long term liabilities?

The current annual long term liabilities of TEVA is $20.81B

What is the all time high annual long term liabilities for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual total long term liabilities is $39.58B

What is Teva Pharmaceutical Industries Limited annual long term liabilities year-on-year change?

Over the past year, TEVA annual total long term liabilities has changed by -$2.30B (-9.94%)

What is Teva Pharmaceutical Industries Limited quarterly total long term liabilities?

The current quarterly long term liabilities of TEVA is $20.99B

What is the all time high quarterly long term liabilities for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly total long term liabilities is $42.43B

What is Teva Pharmaceutical Industries Limited quarterly long term liabilities year-on-year change?

Over the past year, TEVA quarterly total long term liabilities has changed by -$449.00M (-2.09%)
On this page